Table 3.

Univariate Analysis of Overall Survival in TNBC Cancer Patients.

	Overall Survival
	HR	95% CI	Overall P
Age
≤50 ys	1
>50 ys	1.677	1.104–2.546	0.013
Menopausal status
premenopausal	1
postmenopausal	2.216	1.445–3.400	<0.001
Tumor size			<0.001
T1	1
T2	1.588	1.041–2.422	0.032
T3	5.629	2.490–12.725	<0.001
Grade
I-II	1
III	1.367	0.913–2.048	0.129
Lymph node Involvement
−	1
+	2.563	1.725–3.809	<0.001
LVI 1
−	1
+	2.104	1.358–3.258	0.001
Radiotherapy
Yes	1
No	0.784	0.486–1.266	0.319
Chemotherapy
Yes	1
No	1.561	0.806–3.020	0.186
Local treatment			<0.001
BCS2+RT	1
Mastectomy	2.483	1.150–5.362	0.055
Mastectomy
plus RT3	3.72	1.085–12.871	<0.001

¹LVI: lymphvascular invasion.

²BCS: breast conserving surgery.

³RT: radiotherapy.